案例 Products
Hot Products / 相关推荐
2018 - 03 - 05
Immuno-Oncology IntroductionImmuno-therapy has now been representing a significant paradigm shift in cancer treatment after the promising clinical data from the immune-checkpoint m...
2018 - 03 - 02
Gastric Carcinoma     Introduction     Gastric carcinoma remains a common disease with a dismal prognosis. It represents the fourth most frequent mali...
2018 - 03 - 02
With 655,000 deaths worldwide per year, colorectal cancer (CRC) is the second leading cause of cancer-related death in Western society and the incidence and mortality are increasing dramatically in th...
2018 - 03 - 01
Asthma is a chronic inflammatory disorder of the airways in which many infiltrating cells (such as mast cells, eosinophils, T lymphocytes, macrophages, neutrophils, and epithelial cells) and cellular ...
产品名称: Histology Services
型号:
2018 / 03 / 05
Histology ServicesIntroduction     PharmaLegacy (PL) provides contract histology, immunohistochemistry and pathology services to the biopharmaceutical and medical device industry. Whether preparing a single biopsy or a complete study, PL offers high-quality slide preparation, pathological evaluation and report preparation in a timely and cost-effective manner. Our team of highly trained and experienced board-certified veterinary pathologists, skilled and detail-oriented ...
产品名称: DMPK Services
型号:
2018 / 03 / 05
DMPK ServicesPharmaLegacy Models and Research ToolsPharmaLegacy can provide a complete complementary PK/ADME service. Our team of DMPK scientists are dedicated to both discovery and development. This coupled with state-of-the-art instrumentation and supported by an AAALAC accredited vivarium, assists our clients from lead candidate selection through development and ensures a high quality of DMPK studies with cost-efficiency and fast turnaround.Case Study 1 - PK Profiling in Rodent, Non-human Pri...
Copyright ©2013 - 2018 
澎立生物医药技术(上海)有限公司
X
1

QQ设置

3

SKYPE 设置

4

阿里旺旺设置

5

电话号码管理

  • +86-21-6100-2270
6

二维码管理

等待加载动态数据...

等待加载动态数据...

回到顶部
展开